This compound was also tested for mu-opioid receptor action, and like conolidine, was identified to have no exercise at the site. Employing precisely the same paw injection check, numerous alternate options with increased efficacy ended up uncovered that inhibited the Preliminary soreness response, indicating opiate-like exercise. Given the various